
Sign up to save your podcasts
Or
Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.
4.1
2929 ratings
Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.
6,185 Listeners
4,248 Listeners
32,071 Listeners
3,395 Listeners
21,906 Listeners
2,162 Listeners
26,327 Listeners
3,372 Listeners
6,624 Listeners
9,243 Listeners
318 Listeners
30 Listeners
15,371 Listeners
3,303 Listeners
1,170 Listeners